Millennium and Israel Englander Report 2.29M Shares in Beta Bionics

Rhea-AI Filing Summary

Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander disclosed a shared, non‑sole beneficial ownership of 2,286,728 shares of Beta Bionics, Inc. common stock, representing 5.3% of the class. The filing on a Schedule 13G indicates the stake is reported under passive ownership rules, with no sole voting or dispositive power claimed and shared voting and dispositive power of 2,286,728 shares. Addresses and citizenships of the reporting persons are provided and a Joint Filing Agreement is attached.

Positive

• Disclosure of a material passive stake: Reporting persons publicly disclosed an aggregate 5.3% ownership, improving transparency for investors
• Joint Filing Agreement attached: Exhibit I documents coordination among Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander

Negative

• None.

Insights

Financial Analyst

TL;DR: A passive 5.3% stake by Millennium and related parties is disclosed; material sized position, but no control claimed.

The Schedule 13G reports an aggregate 2,286,728-share position in Beta Bionics, equal to 5.3% of outstanding common stock, held with shared voting and dispositive power and no sole power. Filing under Schedule 13G signals passive intent rather than an attempt to influence control. For investors, the key takeaway is the emergence of a sizable institutional holder with voting influence exercised jointly through related entities, documented via a Joint Filing Agreement.

Corporate Governance Expert

TL;DR: Reporting persons disclose shared control over a >5% stake while explicitly denying sole control or intent to change issuer control.

The document shows coordinated reporting by Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander, each claiming shared voting and dispositive power over the same 2,286,728 shares. The certification states the securities were not acquired to influence control. The Joint Filing Agreement (Exhibit I) formalizes the joint filing relationship among the parties.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Beta Bionics, Inc.

(Name of Issuer)

Common Stock, par value $0.0001 per share

(Title of Class of Securities)

08659B102

(CUSIP Number)

09/15/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 08659B102

1

Names of Reporting Persons

Millennium Management LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 2,286,728.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 2,286,728.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

2,286,728.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.3 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

CUSIP No. 08659B102

1

Names of Reporting Persons

Millennium Group Management LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 2,286,728.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 2,286,728.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

2,286,728.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.3 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

CUSIP No. 08659B102

1

Names of Reporting Persons

Israel A. Englander

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 2,286,728.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 2,286,728.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

2,286,728.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.3 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Beta Bionics, Inc.
(b)	Address of issuer's principal executive offices: 11 Hughes, Irvine, California 92618
Item 2.
(a)	Name of person filing: Millennium Management LLC Millennium Group Management LLC Israel A. Englander
(b)	Address or principal business office or, if none, residence: Millennium Management LLC 399 Park Avenue New York, New York 10022 Millennium Group Management LLC 399 Park Avenue New York, New York 10022 Israel A. Englander c/o Millennium Management LLC 399 Park Avenue New York, New York 10022
(c)	Citizenship: Millennium Management LLC - Delaware Millennium Group Management LLC - Delaware Israel A. Englander - United States
(d)	Title of class of securities: Common Stock, par value $0.0001 per share
(e)	CUSIP No.: 08659B102
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: See response to Item 9 on each cover page.
(b)	Percent of class: See response to Item 11 on each cover page.
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: See response to Item 5 on each cover page.
	(ii) Shared power to vote or to direct the vote: See response to Item 6 on each cover page.
	(iii) Sole power to dispose or to direct the disposition of: See response to Item 7 on each cover page.
	(iv) Shared power to dispose or to direct the disposition of: See response to Item 8 on each cover page. The securities disclosed herein as potentially beneficially owned by Millennium Management LLC, Millennium Group Management LLC and Mr. Englander are held by entities subject to voting control and investment discretion by Millennium Management LLC and/or other investment managers that may be controlled by Millennium Group Management LLC (the managing member of Millennium Management LLC) and Mr. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). The foregoing should not be construed in and of itself as an admission by Millennium Management LLC, Millennium Group Management LLC or Mr. Englander as to beneficial ownership of the securities held by such entities.
Item 5.	Ownership of 5 Percent or Less of a Class.
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	If a group has filed this schedule pursuant to §240.13d-1(b)(1)(ii)(K), so indicate under Item 3(k) and attach an exhibit stating the identity and Item 3 classification of each member of the group. If a group has filed this schedule pursuant to §240.13d-1(c) or §240.13d-1(d), attach an exhibit stating the identity of each member of the group. See Exhibit I
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Millennium Management LLC

Signature:	/s/ Gil Raviv
Name/Title:	Gil Raviv, Global General Counsel
Date:	09/18/2025

Millennium Group Management LLC

Signature:	/s/ Gil Raviv
Name/Title:	Gil Raviv, Global General Counsel
Date:	09/18/2025

Israel A. Englander

Signature:	/s/ Israel A. Englander
Name/Title:	Israel A. Englander
Date:	09/18/2025

Exhibit Information

Exhibit I: Joint Filing Agreement, dated as of September 18, 2025, by and among Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander.

FAQ

What stake in Beta Bionics (BBNX) was disclosed in this Schedule 13G?

The filing discloses an aggregate beneficial ownership of 2,286,728 shares, equal to 5.3% of the class.

Who filed the Schedule 13G for Beta Bionics (BBNX)?

The filing was made by Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander.

Does the filing indicate the holders intend to influence control of Beta Bionics?

No. The certification states the securities were not acquired and are not held to change or influence control; the filing is under Schedule 13G passive reporting rules.

Do any of the reporting persons claim sole voting or dispositive power?

No. Each reporting person reports 0 sole voting power and 0 sole dispositive power, with shared voting and dispositive power of 2,286,728 shares.

Is there an agreement among the filers?

Yes. The filing references a Joint Filing Agreement dated September 18, 2025 (Exhibit I).